Pharmaceutical Technology

JUNE 27, 2023

Vertex and Lonza have entered a partnership to establish a facility in Portsmouth, US, to manufacture cell therapies for type 1 diabetes.

Manufacturing 246

Manufacturing 246

Pharmaceutical Technology

MARCH 31, 2023

Moderna has finalised an agreement with the government of the Republic of Kenya to establish an mRNA manufacturing facility in the country. The company is also committed to establishing mRNA manufacturing facilities in Australia, Canada, the US and the UK.

Manufacturing 264

Manufacturing Gene Therapy Gene Genetics 264

Pharmaceutical Technology

SEPTEMBER 14, 2023

Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.

Production 173

Production Drugs 173

Bio Pharma Dive

SEPTEMBER 21, 2023

The Novo Nordisk Foundation’s planned manufacturing facility will help both private companies and academic researchers develop new cell therapies.

Manufacturing 148

Manufacturing Development Research 148

Pharmaceutical Technology

DECEMBER 19, 2023

BioNTech has inaugurated a new messenger RNA (mRNA) vaccine manufacturing facility in Kigali, Rwanda, which will have BioNTainers.

Manufacturing 130

Manufacturing Vaccination Vaccine RNA 130

Pharmaceutical Technology

FEBRUARY 26, 2024

Moderna has announced the conclusion of construction works at its new mRNA manufacturing facility in Canada.

Vaccination 130

Vaccination Vaccine Manufacturing 130

Pharmaceutical Technology

MAY 22, 2023

Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore. The new good manufacturing practices facility was established with support from the Singapore Economic Development Board.

Genetic Analysis 147

Genetic Analysis Manufacturing Drugs Vaccination 147

BioPharma Reporter

APRIL 18, 2024

When imagining a pharmaceutical manufacturing facility, many picture it in a vast rural setting, offering ample space for large-scale operations.

Manufacturing 105

Manufacturing Regulation Marketing 105

Pharmaceutical Technology

MARCH 10, 2023

million ($11 million) grant is being used to build the facility in Bristol where therapies for currently incurable diseases, such as some forms of cancer, sickle cell disease, and cystic fibrosis can be manufactured. The opening of this new facility plays into the UK government’s Life Sciences Industrial Strategy.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

Pharmaceutical Technology

DECEMBER 5, 2022

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. The facility will leverage the infrastructure and labs of both universities and the Translational Research Institute (TRI). .

Research 246

Research Gene Therapy Vaccination Vaccine 246

Pharmaceutical Technology

SEPTEMBER 21, 2023

Novo Nordisk is to invest $136m to develop the Cellerator facility in Lyngby, Denmark, to manufacture cell therapies for clinical trials.

Clinical Trials 147

Clinical Trials Clinical Trials Manufacturing Trials 147

Pharmaceutical Technology

OCTOBER 11, 2023

Gritgen Therapeutics has launched operations at its commercial GMP facility in Suzhou Industrial Park, China.

147

147

Pharma Times

MARCH 28, 2024

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

Research 111

Research Medicine 111

Pharmaceutical Technology

NOVEMBER 14, 2022

Through the acquisition, this Singaporean plant will become the first facility for messenger ribonucleic acid (mRNA) manufacturing in the country. By 2024, the facility is anticipated to generate over 100 jobs in the country across a variety of fields. It will work as the regional headquarters for BioNTech.

Manufacturing 162

Manufacturing Vaccination Vaccine Production 162

Pharmaceutical Technology

SEPTEMBER 4, 2023

Biocon Generics has purchased the US-based oral solid dosage manufacturing facility of Eywa Pharma for a total consideration of $7.7m.

Manufacturing 130

Manufacturing 130

Pharmaceutical Technology

AUGUST 9, 2023

GenScript Biotech has expanded the peptide production capabilities at its new life-sciences manufacturing facility located in Zhenjiang.

Production 130

Production Life Science Manufacturing 130

Pharmaceutical Technology

AUGUST 24, 2023

IDMO Cellares has raised $255m in a Series C financing round for a cell therapy development facility at Bridgewater in New Jersey.

Development 130

Development 130

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 29, 2023

Adoption of eco-friendly designs in healthcare facilities and policy interventions to address shortage of skilled human resources in healthcare is the need of the hour, says Dr. Vivek Desai, founder and managing director, HOSMAC, a hospital planning, management and design consultancy firm.

Clinical Trials 162

Clinical Trials Clinical Trials Clinical Research Trials 162

Pharmaceutical Technology

SEPTEMBER 27, 2023

MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany.

Manufacturing 130

Manufacturing Drugs 130

Pharmaceutical Technology

JUNE 13, 2023

Novo Nordisk has unveiled plans to make a DKr15.9bn ($2.29bn) investment , starting from 2023, to expand its manufacturing facilities in Hillerød, Denmark. The investment will be used for expanding its existing Danish active pharmaceutical ingredient (API) production facility to progress its future serious and chronic disease portfolio.

Manufacturing 130

Manufacturing Production Medicine Development 130

Pharmaceutical Technology

JULY 17, 2023

The Centre for Advanced Imaging (CAI) of the University of Queensland in Australia has unveiled a facility to develop therapies for cancer.

Development 130

Development 130

Pharmaceutical Technology

APRIL 20, 2023

Situated at the hub of the country’s northeastern pharmaceutical corridor, the new facility is staffed by research, application and formulation specialists. The facility complements the company’s current pharma innovation centres in France and Singapore, and intends to improve the patient experience with modern oral dosage forms.

Bioavailability 130

Bioavailability Manufacturing Scientist Development 130

Pharmaceutical Technology

AUGUST 9, 2023

Teknova has opened a new modular manufacturing facility in Hollister, California, US for custom, high-quality life sciences re-agents.

Manufacturing 130

Manufacturing Life Science 130

Pharmaceutical Technology

MARCH 24, 2023

Takeda has unveiled plans to invest almost $764m (JPY100bn) to construct a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. The new facility represents the company’s largest-ever investment in the expansion of manufacturing capacity in the country.

Manufacturing 130

Manufacturing 130

Pharmaceutical Technology

JUNE 9, 2023

The US Food and Drug Administration (FDA) has granted approval to commence commercial production at Bristol Myers Squibb’s new advanced cell therapy manufacturing facility in Devens, Massachusetts. The company operates two further research and development facilities in Cambridge, Massachusetts.

FDA Approval 130

FDA Approval Production Gene Therapy Manufacturing 130

Fierce Pharma

JANUARY 4, 2024

Already with a manufacturing site in Chiba, Japan, AGC Biologics is doubling down on its presence in the country with a new facility in Yokohama. Already with a manufacturing site in Chiba, Japan, AGC Biologics is doubling down on its presence in the country with a new facility in Yokohama.

Manufacturing 107

Manufacturing 107

BioPharma Reporter

MAY 2, 2024

UK-based pharma manufacturer Ennogen has received a Â30 million credit facility from Santander UK to support its international growth strategy.

Manufacturing 52

Manufacturing Regulation Marketing 52

Fierce Pharma

FEBRUARY 26, 2024

Amgen is now open for business in Central Ohio after cutting the ribbon at its “most advanced facility to date.” | Amgen is now open for business in Central Ohio after cutting the ribbon at its “most advanced facility to date.”

116

116

Pharma Mirror

AUGUST 30, 2022

The testing facility, located in North Carolina, provides supportive technology at no cost allowing companies to test and prove their cell-based products at various stages of development. The post Testing Facility Called “Game Changer” in Regenerative Medicine appeared first on Pharma Mirror Magazine.

Medicine 130

Medicine In-Vitro Manufacturing Production 130

pharmaphorum

JANUARY 25, 2024

UK government is reported to be considering financial aid for AstraZeneca to seal a deal to expand a vaccines manufacturing facility in Speke

Vaccination 104

Vaccination Vaccine Manufacturing 104

Outsourcing Pharma

MARCH 6, 2024

Almac Group, a global leader in CDMOs, announced today (March 6) that it has unveiled two new purpose-built facilities at its headquarters in Northern Ireland.

Contract Manufacturing 110

Contract Manufacturing Manufacturing 110

Pharmaceutical Technology

JULY 20, 2023

Biotechnology company SCG Cell Therapy has officially opened its new manufacturing facility and R&D centre at its headquarters in Singapore.

Manufacturing 100

Manufacturing 100

BioPharma Reporter

APRIL 6, 2023

Meissner Corporation â a company which manufactures advanced microfiltration and therapeutic manufacturing systems for pharmaceutical drugs, therapeutics, biologics, and cell and gene therapies - will invest nearly $250m in a new manufacturing facility in Athens-Clarke County in the US.

Manufacturing 139

Manufacturing Gene Therapy Gene Drugs 139

pharmaphorum

NOVEMBER 23, 2023

US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.

Vaccination 104

Vaccination Vaccine 104

Pharma Mirror

APRIL 6, 2022

The upgraded R&D facility is in the Zwijnaarde Science Park, where a cluster of biotech companies are located, and includes state-of-the-art laboratories together with allied services. The post eTheRNA Announces Relocation and Expansion of R&D Facility appeared first on Pharma Mirror Magazine.

Production 130

Production Development Research 130

BioPharma Reporter

SEPTEMBER 19, 2023

The contract development and manufacturing organization (CDMO) Fujifilm Diosynth Biotechnologies has completed a UK manufacturing facility for the production of advanced therapies including viral gene therapies, oncolytic viruses and viral vaccines for use in clinical trials.

Manufacturing 98

Manufacturing Gene Therapy Clinical Trials Clinical Trials 98

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 12, 2023

The Central government has notified the administrative Rules for the Committee for Control and Supervision of Experiments on Animals (CCSEA), the statutory Committee to regulate and monitor experiments on animals to prevent cruelty to animals, with provisions for deemed approval and grading of animal house facilities in medical colleges, pharmacy colleges, (..)

Pharmacy 158

Pharmacy Regulation Vaccination Vaccine 158